Videogame maker says
study shows its game helps manage ADHD symptoms
Send a link to a friend
[October 29, 2015]
By Paul Sandle
LONDON (Reuters) - Children with ADHD
(attention deficit hyperactivity disorder) show signs of improvement
after playing a videogame for 30 minutes a day rather than taking a
pill, the U.S. company developing the treatment said on Wednesday.
|
Diagnoses for ADHD have risen in recent decades, and some 9.5
percent of children aged 3-17 in the United States had the condition
in 2012, according to the Center for Disease Control and Prevention.
Children in the pilot study - 80 aged between eight and 12, half of
which had ADHD - showed improved working memory and levels of
attention, and some parent ratings of symptoms also rose, according
to the results presented at the American Academy of Child and
Adolescent Psychiatry's 62nd annual meeting.
The company, Akili Interactive Labs, said it would now "move full
steam ahead" into a full randomized trial, that if successful would
support a filing with U.S. regulator, the FDA.
Medicating the condition is big business, with Shire - a leading
maker of ADHD drugs, including Vyvanse - saying there were 63
million prescriptions for the condition in the United States last
year, with just under half for children.
Shire is an investor in Akili Interactive Labs, which was founded by
start-up investor PureTech Health.
Eddie Martucci, co-founder and chief executive of Akili Interactive
Labs, said the videogame might also be used in conjuction with
medication.
[to top of second column] |
Called Project EVO, the game is designed to improve a child's
ability to process "cognitive interference" - or multiple streams of
information - potentially helping problem solving ability, working
memory and attention, Martucci said.
In the game, the player has to steer a character down a river while
making decisions about objects that appear on screen.
(Editing by Louise Ireland)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|